Connection
Jennifer Diamond to Cyclin-Dependent Kinase 4
This is a "connection" page, showing publications Jennifer Diamond has written about Cyclin-Dependent Kinase 4.
|
|
Connection Strength |
|
 |
|
 |
|
1.150 |
|
|
|
-
Weiss J, Afghahi A, Shagisultanova E, Diamond JR. Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast Cancer. Oncology (Williston Park). 2018 Oct 15; 32(10):513-5.
Score: 0.629
-
Owsley J, Jimeno A, Diamond JR. Palbociclib:CDK4/6 inhibition in the treatment of ER-positive breast cancer. Drugs Today (Barc). 2016 Feb; 52(2):119-29.
Score: 0.521